NasdaqCM - Nasdaq Real Time Price USD
Equillium, Inc. (EQ)
0.4550
-0.0250
(-5.10%)
As of 12:09:34 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-19,026
-19,026
-21,783
-8,733
-32,081
Investing Cash Flow
13,814
13,814
-4,762
18,684
27,406
Financing Cash Flow
164
164
-9,228
-1,215
31,061
End Cash Position
18,085
18,085
23,216
59,107
50,366
Income Tax Paid Supplemental Data
--
--
580
--
--
Interest Paid Supplemental Data
--
--
946
847
836
Capital Expenditure
-85
-85
-50
-279
-57
Issuance of Capital Stock
--
--
--
--
29,909
Repayment of Debt
--
--
-9,133
-1,429
--
Repurchase of Capital Stock
--
--
-260
--
--
Free Cash Flow
-19,111
-19,111
-21,833
-9,012
-32,138
12/31/2021 - 10/12/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MTVA MetaVia Inc.
0.8277
+1.81%
CDTX Cidara Therapeutics, Inc.
21.04
-3.93%
SPRC SciSparc Ltd.
0.2900
+3.28%
LPTX Leap Therapeutics, Inc.
0.3898
-1.33%
MTNB Matinas BioPharma Holdings, Inc.
0.5912
+1.06%
ATHE Alterity Therapeutics Limited
3.4990
-0.60%
MOLN Molecular Partners AG
4.1500
-0.48%
VTVT vTv Therapeutics Inc.
21.70
+6.84%
GOSS Gossamer Bio, Inc.
0.9505
+6.22%
ADAG Adagene Inc.
1.5094
+5.55%